Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Theriault

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Oncology (Williston Park, N.Y.)|June 19, 2004
Pathophysiology and implications of cancer treatment-induced bone lossRichard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN|September 23, 2009
The role of bisphosphonates in breast cancerRichard L Theriault
Clinical Breast Cancer|April 6, 2005
Strategies to prevent chemotherapy-induced bone loss in women with breast cancerRichard L Theriault
Current Opinion in Obstetrics & Gynecology|November 26, 2009
Bisphosphonates: ready for use as adjuvant therapy of breast cancer?Richard L Theriault
Expert Review of Anticancer Therapy|May 2, 2003
Zoledronic acid (Zometa) use in bone diseaseRichard L Theriault
The Oncologist|February 4, 2012
Health care costs: how do we decide value? When do we decide? How do we particularize the decisions?Richard L Theriault
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Reply to D. Crivellari et alRichard L Theriault, Jennifer K Litton
Women'S Health (London, England)|October 7, 2009
Breast cancer treatment during pregnancyRichard L Theriault, Alyssa G Rieber
Cancer Control : Journal of the Moffitt Cancer Center|April 11, 2012
Biology of bone metastasesRachel L Theriault, Richard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Aromatase inhibitors in postmenopausal breast cancer patientsAlyssa G Rieber, Richard L Theriault
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Oncology (Williston Park, N.Y.)|June 19, 2004
Pathophysiology and implications of cancer treatment-induced bone lossRichard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN|September 23, 2009
The role of bisphosphonates in breast cancerRichard L Theriault
Clinical Breast Cancer|April 6, 2005
Strategies to prevent chemotherapy-induced bone loss in women with breast cancerRichard L Theriault
Current Opinion in Obstetrics & Gynecology|November 26, 2009
Bisphosphonates: ready for use as adjuvant therapy of breast cancer?Richard L Theriault
Expert Review of Anticancer Therapy|May 2, 2003
Zoledronic acid (Zometa) use in bone diseaseRichard L Theriault
The Oncologist|February 4, 2012
Health care costs: how do we decide value? When do we decide? How do we particularize the decisions?Richard L Theriault
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
Reply to D. Crivellari et alRichard L Theriault, Jennifer K Litton
Women'S Health (London, England)|October 7, 2009
Breast cancer treatment during pregnancyRichard L Theriault, Alyssa G Rieber
Cancer Control : Journal of the Moffitt Cancer Center|April 11, 2012
Biology of bone metastasesRachel L Theriault, Richard L Theriault
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Aromatase inhibitors in postmenopausal breast cancer patientsAlyssa G Rieber, Richard L Theriault
Pageof 11